Jane Street Group, LLC Salarius Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$0.16 - $0.42 $1,770 - $4,648	-11,068 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.34 - $0.54 $3,763 - $5,976	11,068 New	11,068 $4,000
Q3 2021 Nov 16, 2021	SELL	$0.8 - $1.15 $16,329 - $23,473	-20,412 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.02 - $1.52 $20,820 - $31,026	20,412 New	20,412 $22,000

Ticker SLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,244,650
Market Cap $5.1M
Description
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.